CVS Caremark Corporation (CVS)

Add a New Bulls Reason Company: CVS Caremark Corporation (CVS) Current price: Headline: (100 character max) Analysis: Cancel 100% agree 8 votes edit Medicare part D Top Contributor: Kryssia Uraguchi | Created when NYSE:CVS was $37.34 | Edit | History Favorable government policy such as Medicare Part D will drive increased drug sales for both prescriptions and generics. This favors CVS's future revenue outlook. (100 character max) Cancel 100% agree 1 votes edit Good at increasing Same Store Sales in acquired stores Top Contributor: Kryssia Uraguchi | Created when NYSE:CVS was $37.34 | Edit | History Remodels of newly acquired Eckerd, Osco, and Sav-on stores will drive revenue and operating margins. (100 character max) Cancel 100% agree 1 votes edit Purchasing power means higher margins on meds Top Contributor: Kryssia Uraguchi | Created when NYSE:CVS was $37.34 | Edit | History Unrivaled economies of scale and purchasing power of the combined company will drive lower prescription prices and higher operating margins. (100 character max) Cancel 0% agree 0 votes edit Recession moves customers towards CVS generics Top Contributor: Will Shikani | Created when NYSE:CVS was $27.82 | Edit | History CVS's Q4 2008 profits increased 17%, largely on customers buying more generic goods. CVS-brand goods, which are cheaper than name brand competing products, have higher profit margins for the company. As the recession continues, the company stands to benefit from more movement towards generic CVS brand sales. (100 character max) Cancel

Worried about pump and dump? We review changes for stock spam » read more

Want to make Wikinvest better? We need your help, contribute today » learn how

Do you write software? We are recruiting the best engineers » view jobs

Like Wikinvest? Spread the word — Tell your friends! » spread the word

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

About | Blog | Advertise | Jobs | Feedback | Help | Get involved